203 related articles for article (PubMed ID: 22870197)
1. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.
Lescarbeau RM; Seib FP; Prewitz M; Werner C; Kaplan DL
PLoS One; 2012; 7(8):e40372. PubMed ID: 22870197
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling.
Lescarbeau RM; Kaplan DL
BMC Cancer; 2014 May; 14():325. PubMed ID: 24885093
[TBL] [Abstract][Full Text] [Related]
4. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth.
Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H
Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105
[TBL] [Abstract][Full Text] [Related]
5. Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis.
Sieh S; Taubenberger AV; Lehman ML; Clements JA; Nelson CC; Hutmacher DW
Bone; 2014 Jun; 63():121-31. PubMed ID: 24530694
[TBL] [Abstract][Full Text] [Related]
6. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW
Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665
[TBL] [Abstract][Full Text] [Related]
7. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
[TBL] [Abstract][Full Text] [Related]
8. One size does not fit all: developing a cell-specific niche for in vitro study of cell behavior.
Marinkovic M; Block TJ; Rakian R; Li Q; Wang E; Reilly MA; Dean DD; Chen XD
Matrix Biol; 2016; 52-54():426-441. PubMed ID: 26780725
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow mesenchymal stem cells increase motility of prostate cancer cells via production of stromal cell-derived factor-1α.
Mognetti B; La Montagna G; Perrelli MG; Pagliaro P; Penna C
J Cell Mol Med; 2013 Feb; 17(2):287-92. PubMed ID: 23301946
[TBL] [Abstract][Full Text] [Related]
10. Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.
Lubik AA; Nouri M; Truong S; Ghaffari M; Adomat HH; Corey E; Cox ME; Li N; Guns ES; Yenki P; Pham S; Buttyan R
Int J Cancer; 2017 Jan; 140(2):358-369. PubMed ID: 27672740
[TBL] [Abstract][Full Text] [Related]
11. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
[TBL] [Abstract][Full Text] [Related]
12. A reconstructed metastasis model to recapitulate the metastatic spread in vitro.
Parikh MR; Minser KE; Rank LM; Glackin CA; Kirshner J
Biotechnol J; 2014 Sep; 9(9):1129-39. PubMed ID: 24919815
[TBL] [Abstract][Full Text] [Related]
13. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
[TBL] [Abstract][Full Text] [Related]
14. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
[TBL] [Abstract][Full Text] [Related]
15. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
Lin J; Adam RM; Santiestevan E; Freeman MR
Cancer Res; 1999 Jun; 59(12):2891-7. PubMed ID: 10383151
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
17. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.
Zhang C; Soori M; Miles FL; Sikes RA; Carson DD; Chung LW; Farach-Carson MC
Prostate; 2011 Feb; 71(2):157-67. PubMed ID: 20665531
[TBL] [Abstract][Full Text] [Related]
18. Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton.
Bogdanos J; Karamanolakis D; Tenta R; Tsintavis A; Milathianakis C; Mitsiades C; Koutsilieris M
Endocr Relat Cancer; 2003 Jun; 10(2):279-89. PubMed ID: 12790789
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
20. Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.
Hurley PJ; Hughes RM; Simons BW; Huang J; Miller RM; Shinder B; Haffner MC; Esopi D; Kimura Y; Jabbari J; Ross AE; Erho N; Vergara IA; Faraj SF; Davicioni E; Netto GJ; Yegnasubramanian S; An SS; Schaeffer EM
Cancer Res; 2015 Oct; 75(20):4322-34. PubMed ID: 26294211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]